Brief: Sophia Genetics, Astrazeneca Spain To Raise Testing For Ovarian Cancer In Spain
07/02/2024 12:48
Feb 7 (Reuters) - Sophia Genetics SA 90B.F :
* SOPHIA GENETICS AND ASTRAZENECA SPAIN COMMIT TO INCREASING
OVARIAN CANCER TESTING IN SPAIN
* SOPHIA GENETICS: EXPANDED EXISTING PROGRAM IN SPAIN TO
INCREASE
ACCESS TO LOCAL TESTING FOR HOMOLOGOUS RECOMBINATION DEFICIENCY
THROUGHOUT COUNTRY
Source text for Eikon: ID:nPre0G4QGa
Further company coverage: 90B.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sophia Genetics SA
See all newsSwitzerland's SOPHiA GENETICS Q2 revenue rises on Liquid Biopsy growth
Brief: Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies
Sophia Genetics dips on $50 mln stock sale
Brief: Sophia Genetics Announces Pricing Of $50 Million Public Offering Of Ordinary Shares
Brief: Sophia Genetics Announces Proposed Public Offering Of Ordinary Shares